Biotechnology

New progress of studies on Lianhua Qingwen's mechanism to fight against SARS-CoV-2

BEIJING, Nov. 4, 2021 /PRNewswire/ -- During the efforts to prevent and control the epidemic, "3 medicines and 3 prescriptions" are selected from traditional Chinese medicine inChina, including the representative medicine "Lianhua Qingwen ", produced by Yiling pharmaceutical, which has been widely...

2021-11-04 12:56 3198

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities inNew Zealand - All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe GAITHERSBURG, Md., Nov. 3, 20...

2021-11-03 22:14 4563

Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX

AUSTIN, Texas, Nov. 3, 2021 /PRNewswire/ -- OncoTEX Inc. (OncoTEX), a US oncology company and member of The iQ Group Global portfolio, is pleased to announce it has acquired a gold compound platform technology that induces the body's immune system to destroy cancer cells. The technology has been...

2021-11-03 22:00 2003

ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence

PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- ERT, the global clinical endpoint technology leader, today announced that following its early Q2 merger with Bioclinica, a technological and scientific leader in medical imaging, the combined company is renamed Clario. Clario is a technology company tha...

2021-11-03 21:33 3890

Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease

SEOUL, South Korea, Nov. 3, 2021 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, announced today that the company had filed PCT ("Patent Cooperation Treaty") patent application covering AI-driven repurposed drugs for primary m...

2021-11-03 21:00 2177

Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021

DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...

2021-11-03 15:00 4321

Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021

DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe Düsseldor...

2021-11-03 15:00 2535

Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join

LONDON, Nov. 3, 2021 /PRNewswire/ -- In his recent opening address to the G20, Italian Prime MinisterMario Draghi highlighted vaccine inequity, emphasizing the fact that only 3% of eligible people living in the world's poorest nations had received any form of COVID-19 vaccine, versus more than 70...

2021-11-03 12:28 2078

Tabernacle Health Group Launches Revolutionary Immunity Booster!

SINGAPORE, Nov. 3, 2021 /PRNewswire/ -- As a result of the pandemic, boosting one's immune system has never been more crucial. Consisting of numerous chemicals, cells, proteins, and tissues that work together, the immune system is responsible for creating, storing, and distributing white blood ce...

2021-11-03 10:00 2797

Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters

* Advancement of Nabota and prescriptions... KRW 290.6B sales and KRW 22.7B operating income * Expanding growth momentum with the release of Fexuprazan in Korea and Nabota inEurope next year SEOUL, South Korea, Nov. 2, 2021 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) (CEOSengho Jeon) a...

2021-11-02 21:00 2136

Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome

SEATTLE and CAMBRIDGE, England, Nov. 2, 2021 /PRNewswire/ -- Nautilus Biotechnology, Inc . (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, andAbcam  (AIM:ABC; NASDA...

2021-11-02 20:16 3567

GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center

PISCATAWAY, New Jersey, Nov. 2, 2021 /PRNewswire/ -- GenScript USA Inc ., the world's leading life science research tools and services provider, announced today that it has opened a larger than 50,000-square-foot facility for highly automated gene synthesis and plasm...

2021-11-02 19:30 2731

New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA

TAIPEI, Nov. 1, 2021 /PRNewswire/ -- TCI Co., Ltd. has long been engaged in the research and development of banana peels and banana stamens, and finally passed the US FDA NDI approval in the middle of this year, becoming the world's first bananaNDI. It is an important milestone for Taiwan's banan...

2021-11-02 09:00 2485

Antengene Granted IND Approval in China for the Phase Ib Study of ATG-008 (Onatasertib) in Combination with ATG-010 (Selinexor) in Patients with Diffuse Large B-Cell Lymphoma

SHANGHAI and HONG KONG, Nov. 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-11-02 08:30 4263

Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments

SINGAPORE, Nov. 2, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. The round was led by Hyfinity Investments, with participation from BioTrack Capital, Legendstar Capital and other investors. Carcell Biopharma is a pre-...

2021-11-02 08:00 3243

Microalgae Milk Pioneer Sophie's Bionutrients Moves to Europe's Alt-protein Hotspot

SINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Singapore-based Sophie's Bionutrients introduced the world's first milk alternative made from protein-rich microalgae earlier this year. CEO and founderEugene Wang now aims to expand the business to the Netherlands to tap into its plant-based protein ecosyst...

2021-11-01 16:29 3164

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

* Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production * Increases up to 60 million vials for commercial drug production per year * Consolidates WuXi Biologics' pioneering the application of innovative technologies such as si...

2021-11-01 10:19 6943

Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma

SHANGHAI and HONG KONG, Nov. 1, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-11-01 08:40 4788

Invetech Named Victorian Top Exporter of the Year

MELBOURNE, Australia, Oct. 30, 2021 /PRNewswire/ -- Invetech, an end-to-end commercialisation partner to world's foremost therapeutic and diagnostic companies, has been named the Victorian Exporter of the Year at the2021 Governor of Victoria Export Awards (GOVEA). Invetech also won the Internatio...

2021-10-30 05:35 4306

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval inAustralia  -- In addition to today's submission to the Therapeutic Goods Administration, the company recently filed for authorization with MHRA, with additional filings in...

2021-10-29 19:15 6688
1 ... 316317318319320321322 ... 349